Clayton’s Basic Pharmacology for Nurses 19th Edition Test Bank – Complete Practice Q&A for Exam Success

,Chapter 1: Drug Definitions, Standards, and Information Sources Test Bank
M M M M M M M M M




MULTIPLEMCHOICE

1. WhatMisMtheMnameMunderMwhichMaMdrugMisMlistedMbyMtheMU.S.MFoodMandMDrugMAdministr
ationM(FDA)?
a. Brand
b. Nonproprietary
c. Official
d. Trademark
ANS:M C
TheMofficialMnameMisMtheMnameMunderMwhichMaMdrugMisMlistedMbyMtheMFDA.MTheMbrandMna
me,MorMtrademark,MisMtheMnameMgivenMtoMaMdrugMbyMitsMmanufacturer.MTheMnonproprietary,
MorMgeneric,MnameMisMprovidedMbyMtheMU.S.MAdoptedMNamesMCouncil.




DIF:MCognitiveMLevel:MKnowledgeMREF:Mp.M1MOBJ:M2TOP:M Nursin
gMProcessMStep:MAssessment
MSC:M NCLEXMClientMNeedsMCategory:MSafe,MEffectiveMCareMEnvironment

2. WhichMsourceMcontainsMinformationMspecificMtoMnutritionalMsupplements?
a. USPMDictionaryMofMUSANM&MInternationalMDrugMNames
b. NaturalMMedicinesMComprehensiveMDatabase
c. UnitedMStatesMPharmacopoeia/NationalMFormularyM(USPMNF)
d. DrugMInteractionMFacts
ANS:M C
UnitedMStatesMPharmacopoeia/NationalMFormularyMcontainsMinformationMspecificMtoMnutrition
alMsupplements.MUSPMDictionaryMofMUSANM&MInternationalMDrugMNamesMisMaMcompilationMof
MdrugMnames,MpronunciationMguide,MandMpossibleMfutureMFDAMapprovedMdrugs;MitMdoesMnotMin

cludeMnutritionalMsupplements.MNaturalMMedicinesMComprehensiveMDatabaseMcontainsMeviden
ceMbasedMinformationMonMherbalMmedicinesMandMherbalMcombinationMproducts;MitMdoesMnotMin
cludeMinformationMspecificMtoMnutritionalMsupplements.MDrugMInteractionMFactsMcontainsMcom
prehensiveMinformationMonMdrugMinteractionMfacts;MitMdoesMnotMincludeMnutritionalMsupplement
s.

DIF:MCognitiveMLevel:MKnowledgeMREF:Mp.M2MOBJ:M4TOP:M Nursin
gMProcessMStep:MAssessment
MSC:M NCLEXMClientMNeedsMCategory:MPhysiologicalMIntegrity

3. WhatMisMtheMmostMcomprehensiveMreferenceMavailableMtoMresearchMaMdrugMinteraction?
a. DrugMFactsMandMComparisons
b. DrugMInteractionMFacts
c. HandbookMonMInjectableM Drugs
d. Martindale—TheMCompleteMDrugMReference
ANS:M B
FirstMpublishedMinM1983,MDrugMInteractionMFactsMisMtheMmostMcomprehensiveMbookMavailabl
eMondrugMinteractions.MInMadditionMtoMmonographsMlistingMvariousMaspectsMofMdrugMinteractio
ns,MthisMinformationMisMreviewedMandMupdatedMbyManMinternationallyMrenownedMgroupMofMphy
siciansMandpharmacistsMwithMclinicalMandMscientificMexpertise.

DIF:MCognitiveMLevel:MComprehensionMREF:Mp.M3MOBJ:M3TOP:

, NursingMProcessMStep:MAssessment
MSC:M NCLEXMClientMNeedsMCategory:MPhysiologicalMIntegrity

4. TheMphysicianMhasMwrittenManMorderMforMaMdrugMwithMwhichMtheMnurseMisMunfamiliar.MWhichM
sectionMofMtheMPhysicians’MDeskMReferenceM(PDR)MisMmostMhelpfulMtoMgetMinformationMaboutM
thisMdrug?
a. Manufacturer’sMsection
b. BrandMandMGenericMNameMsection
c. ProductMCategoryMsection
d. ProductMInformationMsectio
nMANS:MB

DIF:MCognitiveMLevel:MComprehensionMREF:Mp.M3MOBJ:M4TOP:
NursingMProcessMStep:MPlanning
MSC:M NCLEXMClientMNeedsMCategory:MPhysiologicalMIntegrity

5. WhichMonlineMdrugMreferenceMmakesMavailableMtoMhealthMcareMprovidersMandMtheMpublicM
aMstandard,Mcomprehensive,MupMtoMdateMlookMupMandMdownloadableMresourceMaboutMmedic
ines?
a. AmericanMDrugMIndex
b. AmericanMHospitalMFormulary
c. DailyMed
d. Physicians’MDeskMReferenceM(PDR)
ANS:M C
DailyMedMmakesMavailableMtoMhealthMcareMprovidersMandMtheMpublicMaMstandard,Mcomprehensi
ve,MupMtoMdateMlookMupMandMdownloadableMresourceMaboutMmedicines.MTheMAmericanMDrugMI
ndexMisMnotMappropriateMforMpatientMuse.MTheMAmericanMHospitalMFormularyMisMnotMappropria
teMforMpatientMuse.MTheMPDRMisMnotMappropriateMforMpatientMuse.

DIF:MCognitiveMLevel:MKnowledgeMREF:Mp.M4MOBJ:M5TOP:M Nursin
gMProcessMStep:MImplementation
MSC:M NCLEXMClientMNeedsMCategory:MPhysiologicalMIntegrity

6. WhichMlegislationMauthorizesMtheMFDAMtoMdetermineMtheMsafetyMofMaMdrugMbeforeMitsMmarketing?
a. FederalMFood,MDrug,MandMCosmeticMActM(1938)
b. DurhamMHumphreyMAmendmentM(1952)
c. ControlledMSubstancesMActM(1970)
d. KefauverMHarrisMDrugMAmendmentM(1962)
ANS:M A
TheMFederalMFood,MDrug,MandMCosmeticMActMofM1938MauthorizedMtheMFDAMtoMdetermineMtheM
safetyMofMallMdrugsMbeforeMmarketing.MLaterMamendmentsMandMactsMhelpedMtightenMFDAMcont
rolMandMensureMdrugMsafety.MTheMDurhamMHumphreyMAmendmentMdefinesMtheMkindsMofMdrug
sMthatMcannotMbeMusedMsafelyMwithoutMmedicalMsupervisionMandMrestrictsMtheirMsaleMtoMprescrip
tionMbyMaMlicensedMpractitioner.MTheMControlledMSubstancesMActMaddressesMonlyMcontrolledMsu
bstancesMandMtheirMcategorization.MTheMKefauverMHarrisMDrugMAmendmentMensuresMdrugMeffi
cacyMandMgreaterMdrugMsafety.MDrugMmanufacturersMareMrequiredMtoMproveMtoMtheMFDAMtheMeff
ectivenessMofMtheirMproductsMbeforeMmarketingMthem.

DIF:MCognitiveMLevel:MKnowledgeMREF:Mp.M4MOBJ:M8TOP:M Nursin
gMProcessMStep:MAssessment
MSC:M NCLEXMClientMNeedsMCategory:MPhysiologicalMIntegrity

7. MeperidineM(Demerol)MisMaMnarcoticMwithMaMhighMpotentialMforMphysicalMandMpsychological

, dependency.MUnderMwhichMclassificationMdoesMthisMdrugMfall?
a. I
b. II
c. III
d. IV
ANS:M B
MeperidineM(Demerol)MisMaMScheduleMIIMdrug;MitMhasMaMhighMpotentialMforMabuseMandMmayMlea
dMtoMsevereMpsychologicalMandMphysicalMdependence.MScheduleMIMdrugsMhaveMhighMpotentialMf
orMabuseMandMnoMrecognizedMmedicalMuse.MScheduleMIIIMdrugsMhaveMsomeMpotentialMforMabuse
.MUseMmayMleadMtoMlowMtoMmoderateMphysicalMdependenceMorMhighMpsychologicalMdependence
.MScheduleMIVMdrugsMhaveMlowMpotentialMforMabuse.MUseMmayMleadMtoMlimitedMphysicalMorMps
ychologicalMdependence.

DIF:MCognitiveMLevel:MComprehensionMREF:Mp.M4M|Mp.M5MOBJ:M7TO
P:MNursingMProcessMStep:MAssessment
MSC:M NCLEXMClientMNeedsMCategory:MSafe,MEffectiveMCareMEnvironment

8. WhatMwouldMtheMFDAMdoMtoMexpediteMdrugMdevelopmentMandMapprovalMforManMoutbrea
kMofMsmallpox,MforMwhichMthereMisMnoMknownMtreatment?
a. ListMsmallpoxMasMaMhealthMorphanMdisease.
b. OmitMtheMpreclinicalMresearchMphase.
c. ExtendMtheMclinicalMresearchMphase.
d. FastMtrackMtheMinvestigationalMdrug.
ANS:M D
OnceMtheMInvestigationalMNewMDrugMApplicationMhasMbeenMapproved,MtheMdrugMcanMreceiveM
highestMpriorityMwithinMtheMagency,MwhichMisMcalledMfastMtracking.MAMsmallpoxMoutbreakMwo
uldMbecomeMaMpriorityMconcernMinMtheMworld.MOrphanMdiseasesMareMnotMresearchedMinMaMprior
ityMmanner.MPreclinicalMresearchMisMnotMomitted.MExtendingManyMphaseMofMtheMresearchMwoul
dMmeanMaMlongerMtimeMtoMdevelopMaMvaccine.MTheMFDAMmustMensureMthatMallMphasesMofMtheMp
reclinicalMandMclinicalMresearchMphaseMhaveMbeenMcompletedMinMaMsafeMmanner.

DIF:MCognitiveMLevel:MKnowledgeMREF:Mp.M7MOBJ:M8TOP:M Nursin
gMProcessMStep:MAssessment

MSC:M NCLEXMClientMNeedsMCategory:MSafe,MEffectiveMCareMEnvironment

9. WhichMstatementMisMtrueMaboutMoverMtheMcounterM(OTC)Mdrugs?
a. TheyMareMnotMlistedMinMtheMUSPMNF.
b. AMprescriptionMfromMaMhealthMcareMproviderMisMneeded.
c. TheyMareMsoldMwithoutMaMprescription.
d. TheyMareMknownMonlyMbyMtheirMbrandMnames.
ANS:M C
OTCMmedicationsMdoMnotMrequireMaMprescription.MAMvarietyMofMnames,MbothMgenericMandMtrad
e,McanMbeMusedMforMindividualMdrugsMsoldMOTC.MOTCMdrugsMareMlistedMinMtheMUSPMNF.MPrescr
iptionMdrugsMrequireManMorderMbyMaMhealthMprofessionalMwhoMisMlicensedMtoMprescribe,MsuchMa
sMaMphysician,MnurseMpractitioner,MphysicianMassistant,MorMdentist.

DIF:MCognitiveMLevel:MComprehensionMREF:Mp.M2MOBJ:M2TOP:MNu
rsingMProcessMStep:MPlanning
MSC:M NCLEXMClientMNeedsMCategory:MPhysiologicalMIntegrity

10. WhichMisMtheMmostMauthoritativeMreferenceMforMmedicationsMthatMareMinjected?